Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

361 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Surgical therapy for pulmonary metastases from malignant melanoma].
Macherey S, Schlaak M, Doerr F, Grönke S, Heldwein M, Quaas A, Zander T, Hekmat K. Macherey S, et al. Among authors: schlaak m. Hautarzt. 2015 Jan;66(1):65-73. doi: 10.1007/s00105-014-3555-z. Hautarzt. 2015. PMID: 25576143 Review. German.
[Current therapy of non-melanoma skin cancer].
Schlaak M, von Bartenwerffer W, Mauch C. Schlaak M, et al. Hautarzt. 2011 Jun;62(6):430-5. doi: 10.1007/s00105-010-2044-2. Hautarzt. 2011. PMID: 21556962 Review. German.
[Merkel cell carcinoma].
Kleffner F, Schürholz J, Burckhardt S, Mauch C, Schlaak M. Kleffner F, et al. Among authors: schlaak m. Hautarzt. 2014 Sep;65(9):823-30; quiz 831-2. doi: 10.1007/s00105-014-2854-8. Hautarzt. 2014. PMID: 25234632 German.
[Dermatology continuing medical education during Corona times and beyond : Experience from the 2020 digital advanced training week for practical dermatology and venerology and lessons for future concepts].
Prinz JC, Hartmann D, Wolff H, Schlaak MS, Pilz J, Ruzicka T, Preußner M, Kiendl C, Greger J, Mutke S, French LE. Prinz JC, et al. Among authors: schlaak ms. Hautarzt. 2021 Apr;72(4):362-366. doi: 10.1007/s00105-020-04755-4. Epub 2021 Jan 18. Hautarzt. 2021. PMID: 33459802 Free PMC article. German. No abstract available.
Real-world outcomes using PD-1 antibodies and BRAF + MEK inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and Switzerland.
Schumann K, Mauch C, Klespe KC, Loquai C, Nikfarjam U, Schlaak M, Akçetin L, Kölblinger P, Hoellwerth M, Meissner M, Mengi G, Braun AD, Mengoni M, Dummer R, Mangana J, Sindrilaru MA, Radmann D, Hafner C, Freund J, Rappersberger K, Weihsengruber F, Meiss F, Reinhardt L, Meier F, Rainer B, Richtig E, Ressler JM, Höller C, Eigentler T, Amaral T, Peitsch WK, Hillen U, Harth W, Ziller F, Schatton K, Gambichler T, Susok L, Maul LV, Läubli H, Debus D, Weishaupt C, Börger S, Sievers K, Haferkamp S, Zenderowski V, Nguyen VA, Wanner M, Gutzmer R, Terheyden P, Kähler K, Emmert S, Thiem A, Sachse M, Gercken-Riedel S, Kaune KM, Thoms KM, Heinzerling L, Heppt MV, Tratzmiller S, Hoetzenecker W, Öllinger A, Steiner A, Peinhaupt T, Podda M, Schmid S, Wollina U, Biedermann T, Posch C. Schumann K, et al. Among authors: schlaak m. J Eur Acad Dermatol Venereol. 2023 May;37(5):894-906. doi: 10.1111/jdv.18779. Epub 2022 Dec 12. J Eur Acad Dermatol Venereol. 2023. PMID: 36433688
361 results